Vemurafenib-Induced Neutrophilic Panniculitis in a Child with a Brainstem Glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vemurafenib-Induced Neutrophilic Panniculitis in a Child with a Brainstem Glioma

Published:2014-03-06 Issue:1 Volume:32 Page:153-154
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:Pediatr Dermatol

Author:

West Emily S.¹,Williams Victoria L.²³,Morelli Joseph G.²³⁴

Affiliation:

1. Columbia University College of Physicians and Surgeons; New York New York

2. Department of Dermatology; School of Medicine; University of Colorado Anschutz Medical Campus; Aurora Colorado

3. Department of Pediatric Dermatology; School of Medicine; University of Colorado Anschutz Medical Campus; Aurora Colorado

4. Department of Pediatrics; School of Medicine; University of Colorado Anschutz Medical Campus; Aurora Colorado

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pde.12316/fullpdf

Reference5 articles.

1. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

2. Brainstem ganglioglioma successfully treated with vemurafenib;Rush;J Clin Oncol,2013

3. Cutaneous toxic effects associated with vemurafenib and inhibition of the BRAF pathway;Huang;Arch Dermatol,2012

4. Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib;Kim;J Cutan Pathol,2013

5. Neutrophilic panniculitis;Sutra-Loubet;J Am Acad Dermatol,2004

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy;European Journal of Dermatology;2023-04

2. Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic review;Pediatric Blood & Cancer;2021-09-26

3. Cutaneous adverse events in children treated with vemurafenib for refractory BRAF V600E mutated Langerhans cell histiocytosis;Pediatric Blood & Cancer;2021-06-09

4. Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy;Pediatric Dermatology;2020-12-30

5. Hypodermite sous inhibiteur de BRAF et/ou inhibiteur de MEK : revue de la littérature à partir d’une nouvelle observation;Annales de Dermatologie et de Vénéréologie;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3